⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 16, 2026Open Access

Innovative therapy in European Parliament's positions: a numerical science-based vocabulary analysis

Thomas Allouche Valentin Brunel Frédéric Béchet Marie Glinel Aurélie Mahalatchimy

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to analyze the vocabulary used by the European Parliament regarding innovative therapies.
Conducted a numerical analysis of vocabulary in official texts from the European Parliament.
Focused on positions related to gene and cell therapies.
Identified key terms and trends in the discussions.
Highlighted significant terminology used in relation to innovative therapies.
Demonstrated the evolution of language in policy discussions over time.
Revealed patterns in how different therapy approaches are discussed.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Poster presents a vocabulary analysis of European Parliament's positions on innovative therapy, suggesting implications for policy-making.

Abstract

Poster presented at the 2023 European Society of Gene & Cell Therapy Congress in Brussels.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Allouche et al. (2026) studied this question.

synapsesocial.com/papers/69bb92df496e729e629807d0 https://doi.org/10.5281/zenodo.19050217

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT)2024 · 30 citations
2Disparities in access to gene therapy in the European Union: ethical and regulatory challenges2025 · 4 citations
3The European landscape for gene therapies in orphan diseases: 6-year experience with the EMA Committee for Orphan Medicinal ProductsOriginal Research · 2023 · 16 citations
4Cell and gene therapy in Germany: three decades of advanced technologies2025
5The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder ApproachOriginal Research · 2026

More related papers

A Decade of Innovation: Medicinal Products with New Active Substances Centrally Authorized Within the EU Between 2011 and 20202026
P0123Therapy shapes disease: Biologic exposure drives extracellular matrix reprogramming in ulcerative colitis2026
DOP049Transcriptomic profiling reveals divergent molecular pathways underlying Ulcerative Colitis disease activity and prognostic severity2026